First Pharma Fund
STAG Fund Management
First Pharma Fund
First Pharma Fund
First Pharma Fund is a closed-end alternative investment fund regulated by CMVM (ID: 2101) and managed by STAG Fund Management, investing in private equity with a minimum commitment of €500,000.
- Manager
- STAG Fund Management
- Regulator
- CMVM (ID: 2101)
- ISIN
- PTSFQGIM0005
- Strategy
- Private Equity
- Min. Investment
- €500,000
- Fund Size
- Not disclosed
- Management Fee
- Not disclosed
- Performance Fee
- Not disclosed
- Lock-up
- Not disclosed
- Redemptions
- Not disclosed
- Status
- Open
- GV-intended
- Manager-stated GV intent
Investor decision panel
What to know before shortlisting this fund
Best for
- Investors seeking private equity exposure through a Portugal-regulated fund.
- Investors who need a fund currently open for subscriptions.
Avoid if
- You need clear liquidity terms before first contact.
- You need a complete fee schedule before comparing net returns.
- You are a US person and need confirmed FATCA/PFIC handling.
Key unknowns
- Fund size
- Management fee
- Performance fee
- Custodian
- Auditor
Main diligence flags
- No major flags detected. Confirm current documents before investing.
Golden Visa note: The manager states this fund is intended for Golden Visa applicants, but this claim is not shown as independently verified here.
Fund Snapshot
Key Facts
Fees
Additional Details
Compliance
Capital at risk. Past performance isn't indicative of future returns. This is not investment advice.
Historical Performance
About the Fund
A CMVM-regulated Portuguese venture capital fund (FCR) focused on the community-pharmacy sector, acquiring and operating licensed pharmacies, and structured as a Golden Visa-eligible, non-real-estate route.
The First Pharma Fund is a closed-end Portuguese venture capital fund (Fundo de Capital de Risco) managed by STAG Fund Management SCR and regulated by the CMVM (registration 2101). It pursues a buy-and-build strategy in the Portuguese community-pharmacy sector, acquiring licensed pharmacies and professionalising their operations to grow revenue and margins, with exits via strategic sale. Investors seeking to qualify for the Portuguese Golden Visa must subscribe at least EUR 500,000 in eligible fund units and hold them for the legal minimum period. Because the exposure is to operating pharmacy businesses rather than property, the fund is positioned as a non-real-estate, Golden Visa-eligible vehicle. Detailed fee, custodian and auditor information is held by the manager and is pending collection; fund data is provided by the manager and pending independent verification.
Regulatory Identifiers
We source from CMVM-regulated managers where applicable. Verify each fund's registration and GV suitability with counsel.
Key Terms
Information as reported by fund manager. Terms may vary by investor class.
Fees
Fee Structure
Fee Calculator
Fund Category
View all funds in this category
Regulatory & Compliance
Always confirm regulatory details with the fund manager and legal counsel before investing.
Fund Team
8 team members
Team members are employed by the fund manager, not Movingto. Profiles listed for directory comparison.
António Pereira brings deep operational and regulatory expertise to STAG, where he oversees core business functions, financial operations, and...
Diogo Saraiva de Ponte is an experienced investment leader who has managed more than €1 billion across global private equity, real estate and...
Gisela leads STAG’s Legal and Compliance functions, ensuring adherence to regulatory requirements across all funds. With more than 20 years of...
Manuel leads STAG’s Real Estate division, bringing over a decade of international experience in investment management, financial oversight, and...
Nathan leads Business Development at STAG Fund Management, focusing on international client acquisition, strategic partnerships, and tailored...
Francisco serves as Investor Relations at STAG Fund Management, combining a marketing background with hands-on experience across acquisitions, asset...
Enquire About First Pharma Fund
Speak with a MovingTo advisor about this fund. Our team will review your enquiry and get back to you.
Disclaimer: This enquiry does not constitute investment advice or a commitment to invest. All investments carry risk. Past performance does not guarantee future results.
Important Notice for Investors
Investment in funds involves risks, including the possible loss of principal. Please read all fund documentation carefully before making any investment decisions. Past performance is not indicative of future results.
Using Industry Assumptions
This fund hasn't specified target returns. You can adjust the assumptions below to project potential outcomes.Contact the fund for precise targets.
Fee data incomplete
Missing Management fee, Performance fee. Net-return estimates use known fees only and should not be read as final cost projections.
Investment Calculator
Project potential returns based on your investment parameters
Display returns after disclosed management and performance fees
Fund minimum: €500,000
Typical holding period
Industry average assumption
Using Industry Assumptions: This projection uses market averages as the fund hasn't specified target returns. Actual performance may differ significantly. Contact the fund manager for fund-specific projections.
Investment Risk Disclosure: These projections are for illustrative purposes only and do not guarantee future performance. Past performance is not indicative of future results. All investments carry risk, including potential loss of principal. Consult with a qualified financial advisor before making investment decisions.
Frequently Asked Questions
Verify current subscription documents, fee schedule, liquidity terms, tax treatment, custodian/auditor evidence, and fund-route evidence with Portuguese legal counsel. Current key unknowns: Fund size, Management fee, Performance fee, Custodian, Auditor.
The listed minimum investment is €500,000. Redemption frequency is not disclosed and lock-up is not disclosed. Confirm final terms in the fund documents.
This profile currently has limited data completeness (36%). No major flags are currently detected.
No. Verification means selected regulatory, identity, and document checks have been reviewed. It is not financial advice, a suitability assessment, or a guarantee of a Golden Visa outcome or investment performance.
The listed target return is Not disclosed. Past performance and targets are not guarantees. Model net returns only after confirming complete fee and liquidity terms.
The profile lists CMVM ID 2101. Investors should verify current registry status and documents before subscribing.
Management fee: Not disclosed. Performance fee: Not disclosed. Subscription fee: Not disclosed. Missing fee fields should be treated as diligence gaps, not as zero-cost assumptions.
The profile marks this fund as Golden Visa intended. Fund-route evidence must still be confirmed against current law, fund documents, and the applicant's own legal file.
How does this Private Equity fund stack up?
Compare fees, returns, and key terms across all Private Equity Golden Visa funds.
See how this fund compares to other Private Equity Golden Visa funds →Looking for all Golden Visa funds in one place?
Browse every fund with fees, returns, and key details side by side.
View the Complete Fund Directory →